Chimeric HDAC inhibitors: Comprehensive review on the HDAC-based strategies developed to combat cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Chimeric HDAC inhibitors: Comprehensive review on the HDAC-based strategies developed to combat cancer
Authors
Keywords
-
Journal
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-05-07
DOI
10.1002/med.21505
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design, synthesis and evaluate of novel dual FGFR1 and HDAC inhibitors bearing an indazole scaffold
- (2018) Jian Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Camptothecin-psammaplin A hybrids as topoisomerase I and HDAC dual-action inhibitors
- (2018) Raffaella Cincinelli et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Preclinical Evaluation of Fused Pyrimidine-Based Hydroxamates for the Treatment of Hepatocellular Carcinoma
- (2018) Dizhong Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of N1-(4-((7-Cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)phenyl)-N8-hydroxyoctanediamide as a Novel Inhibitor Targeting Cyclin-dependent Kinase 4/9 (CDK4/9) and Histone Deacetlyase1 (HDAC1) against Malignant Cancer
- (2018) Yongtao Li et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors
- (2018) Jay H. Kalin et al. Nature Communications
- Inhibiting Histone Deacetylase as a Means to Reverse Resistance to Angiogenesis Inhibitors: Phase I Study of Abexinostat Plus Pazopanib in Advanced Solid Tumor Malignancies
- (2017) Rahul Aggarwal et al. JOURNAL OF CLINICAL ONCOLOGY
- Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors
- (2017) Guoqiang Dong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat
- (2017) Lianbin Yao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nitric Oxide Donor-Based Cancer Therapy: Advances and Prospects
- (2017) Zhangjian Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Reversal of platinum drug resistance by the histone deacetylase inhibitor belinostat
- (2017) Kenneth Kin-Wah To et al. LUNG CANCER
- Functions of bromodomain-containing proteins and their roles in homeostasis and cancer
- (2017) Takao Fujisawa et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Design, Synthesis, and Biological Evaluation of the First c-Met/HDAC Inhibitors Based on Pyridazinone Derivatives
- (2017) Dong Lu et al. ACS Medicinal Chemistry Letters
- Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery
- (2017) Wei Chen et al. ACS Medicinal Chemistry Letters
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy
- (2017) Wennan Zhao et al. Acta Pharmaceutica Sinica B
- Cancer Stem Cells: Basic Concepts and Therapeutic Implications
- (2016) Dany Nassar et al. Annual Review of Pathology-Mechanisms of Disease
- Targeting prostate cancer with compounds possessing dual activity as androgen receptor antagonists and HDAC6 inhibitors
- (2016) Pradeep S. Jadhavar et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeting epigenetic reader and eraser: Rational design, synthesis and in vitro evaluation of dimethylisoxazoles derivatives as BRD4/HDAC dual inhibitors
- (2016) Zhimin Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Design and Synthesis of Janus Kinase 2 (JAK2) and Histone Deacetlyase (HDAC) Bispecific Inhibitors Based on Pacritinib and Evidence of Dual Pathway Inhibition in Hematological Cell Lines
- (2016) Eugene Guorong Yang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Roles of eukaryotic topoisomerases in transcription, replication and genomic stability
- (2016) Yves Pommier et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Role of Natural Stilbenes in the Prevention of Cancer
- (2016) J. Antoni Sirerol et al. Oxidative Medicine and Cellular Longevity
- Targeting HDAC with a novel inhibitor effectively reverses paclitaxel resistance in non-small cell lung cancer via multiple mechanisms
- (2016) L Wang et al. Cell Death & Disease
- Design, synthesis and biological evaluation of 2-amino-N-(2-aminophenyl)thiazole-5-carboxamide derivatives as novel Bcr-Abl and histone deacetylase dual inhibitors
- (2016) Xin Chen et al. RSC Advances
- Epigenetic polypharmacology: from combination therapy to multitargeted drugs
- (2016) Angel R. de Lera et al. Clinical Epigenetics
- Design, synthesis and evaluation of antiestrogen and histone deacetylase inhibitor molecular hybrids
- (2015) Rodrigo Mendoza-Sanchez et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Hybrids from 4-anilinoquinazoline and hydroxamic acid as dual inhibitors of vascular endothelial growth factor receptor-2 and histone deacetylase
- (2015) Fan-Wei Peng et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Enzalutamide: targeting the androgen signalling pathway in metastatic castration-resistant prostate cancer
- (2015) Jack Schalken et al. BJU INTERNATIONAL
- A DNA/HDAC dual-targeting drug CY190602 with significantly enhanced anticancer potency
- (2015) C. Liu et al. EMBO Molecular Medicine
- Design and structure activity relationship of tumor-homing histone deacetylase inhibitors conjugated to folic and pteroic acids
- (2015) Quaovi H. Sodji et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Macrocyclic compounds as anti-cancer agents: Design and synthesis of multi-acting inhibitors against HDAC, FLT3 and JAK2
- (2015) Cheng-Qing Ning et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Design, synthesis and biological evaluation of colchicine derivatives as novel tubulin and histone deacetylase dual inhibitors
- (2015) Xuan Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents
- (2015) Kai Xue et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Design, Synthesis, and Antitumor Evaluation of Novel Histone Deacetylase Inhibitors Equipped with a Phenylsulfonylfuroxan Module as a Nitric Oxide Donor
- (2015) Wenwen Duan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Novel Bioactive Hybrid Compound Dual Targeting Estrogen Receptor and Histone Deacetylase for the Treatment of Breast Cancer
- (2015) Chu Tang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors
- (2015) Shipeng He et al. ACS Medicinal Chemistry Letters
- A novel small molecule hybrid of vorinostat and DACA displays anticancer activity against human hormone-refractory metastatic prostate cancer through dual inhibition of histone deacetylase and topoisomerase I
- (2014) Chia-Chun Yu et al. BIOCHEMICAL PHARMACOLOGY
- Rational approaches, design strategies, structure activity relationship and mechanistic insights for anticancer hybrids
- (2014) Kunal Nepali et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Polypharmacology: Challenges and Opportunities in Drug Discovery
- (2014) Andrew Anighoro et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeting Microtubules by Natural Agents for Cancer Therapy
- (2014) E. Mukhtar et al. MOLECULAR CANCER THERAPEUTICS
- Histone deacetylase inhibitor (HDACI) mechanisms of action: Emerging insights
- (2014) Prithviraj Bose et al. PHARMACOLOGY & THERAPEUTICS
- Synthesis of hybrid anticancer agents based on kinase and histone deacetylase inhibitors
- (2014) Hiren Patel et al. MedChemComm
- The structure based design of dual HDAC/BET inhibitors as novel epigenetic probes
- (2014) Stephen J. Atkinson et al. MedChemComm
- Novel Antiproliferative Chimeric Compounds with Marked Histone Deacetylase Inhibitory Activity
- (2014) Elisa Giacomini et al. ACS Medicinal Chemistry Letters
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Selectively Targeting Prostate Cancer with Antiandrogen Equipped Histone Deacetylase Inhibitors
- (2013) Berkley E. Gryder et al. ACS Chemical Biology
- Histone deacetylase inhibitors
- (2013) Marije Slingerland et al. ANTI-CANCER DRUGS
- The discovery and optimization of novel dual inhibitors of topoisomerase ii and histone deacetylase
- (2013) Xuan Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- The discovery of colchicine-SAHA hybrids as a new class of antitumor agents
- (2013) Xuan Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Discovery of a small molecular compound simultaneously targeting RXR and HADC: Design, synthesis, molecular docking and bioassay
- (2013) Guo-Liang Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Dual-acting histone deacetylase-topoisomerase I inhibitors
- (2013) William Guerrant et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- A Chimeric SERM-Histone Deacetylase Inhibitor Approach to Breast Cancer Therapy
- (2013) Hitisha K. Patel et al. ChemMedChem
- United States Food and Drug Administration approved oral kinase inhibitors for the treatment of malignancies
- (2013) Woondong Jeong et al. CURRENT PROBLEMS IN CANCER
- Folate and folate receptor alpha antagonists mechanism of action in ovarian cancer
- (2013) Christen L. Walters et al. GYNECOLOGIC ONCOLOGY
- Histone Deacetylase Inhibitors Equipped with Estrogen Receptor Modulation Activity
- (2013) Berkley E. Gryder et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design and Synthesis of Dual-Action Inhibitors Targeting Histone Deacetylases and 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase for Cancer Treatment
- (2013) Jhih-Bin Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Anti-cancer mechanisms of clinically acceptable colchicine concentrations on hepatocellular carcinoma
- (2013) Zu-Yau Lin et al. LIFE SCIENCES
- Potential Advantages of CUDC-101, a Multitargeted HDAC, EGFR, and HER2 Inhibitor, in Treating Drug Resistance and Preventing Cancer Cell Migration and Invasion
- (2013) J. Wang et al. MOLECULAR CANCER THERAPEUTICS
- The Design and Synthesis of a New Class of RTK/HDAC Dual-Targeted Inhibitors
- (2013) Xuan Zhang et al. MOLECULES
- Development of a Chimeric c-Src Kinase and HDAC Inhibitor
- (2013) Kristin S. Ko et al. ACS Medicinal Chemistry Letters
- Mechanisms and insights into drug resistance in cancer
- (2013) Hiba Zahreddine et al. Frontiers in Pharmacology
- Tamoxifen Resistance in Breast Cancer
- (2012) Min-Sun Chang Biomolecules & Therapeutics
- Design, synthesis and evaluation of novel metalloproteinase inhibitors based on l-tyrosine scaffold
- (2012) Xian-Chao Cheng et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Synthesis and biological evaluation of N-aryl salicylamides with a hydroxamic acid moiety at 5-position as novel HDAC–EGFR dual inhibitors
- (2012) Miao Zuo et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Cancer Network Disruption by a Single Molecule Inhibitor Targeting Both Histone Deacetylase Activity and Phosphatidylinositol 3-Kinase Signaling
- (2012) C. Qian et al. CLINICAL CANCER RESEARCH
- Targeting the EGFR signaling pathway in cancer therapy
- (2012) Parthasarathy Seshacharyulu et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Challenges in the design of multitarget drugs against multifactorial pathologies: a new life for medicinal chemistry?
- (2012) Luca Costantino et al. Future Medicinal Chemistry
- Histone deacetylases and cancer
- (2012) Bruna Barneda-Zahonero et al. Molecular Oncology
- The Dark Side of Protein Kinase CK2 Inhibition
- (2011) G. Cozza et al. CURRENT MEDICINAL CHEMISTRY
- Inhibition of Ras for cancer treatment: the search continues
- (2011) Antonio T Baines et al. Future Medicinal Chemistry
- HDAC inhibitors in cancer biology: emerging mechanisms and clinical applications
- (2011) Omar Khan et al. IMMUNOLOGY AND CELL BIOLOGY
- Vitamin D as a promising anticancer agent
- (2011) ChandraKanti Chakraborti INDIAN JOURNAL OF PHARMACOLOGY
- HDAC6 α-tubulin deacetylase: A potential therapeutic target in neurodegenerative diseases
- (2011) Guoyi Li et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Photodynamic therapy based on 5-aminolevulinic acid and its use as an antimicrobial Agent
- (2011) Frederick Harris et al. MEDICINAL RESEARCH REVIEWS
- An overview of the c-MET signaling pathway
- (2011) Shawna Leslie Organ et al. Therapeutic Advances in Medical Oncology
- Vitamin D receptor agonist/histone deacetylase inhibitor molecular hybrids
- (2010) Marc Lamblin et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Structure–activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives
- (2010) Shinya Mitsuhashi et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylase based on a cinnamic hydroxamic acid core structure
- (2010) Liqiang Chen et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Inside HDAC with HDAC inhibitors
- (2010) Philippe Bertrand EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
- (2010) Chrisostomi Gialeli et al. FEBS Journal
- Discovery of 7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide (CUDC-101) as a Potent Multi-Acting HDAC, EGFR, and HER2 Inhibitor for the Treatment of Cancer
- (2010) Xiong Cai et al. JOURNAL OF MEDICINAL CHEMISTRY
- A novel anti-cancer bifunctional platinum drug candidate with dual DNA binding and histone deacetylase inhibitory activity
- (2009) Darren Griffith et al. CHEMICAL COMMUNICATIONS
- Design of Chimeric Histone Deacetylase- and Tyrosine Kinase-Inhibitors: A Series of Imatinib Hybrides as Potent Inhibitors of Wild-Type and Mutant BCR-ABL, PDGF-Rβ, and Histone Deacetylases†
- (2009) Siavosh Mahboobi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross-resistance to a wide range of DNA-damaging drugs
- (2008) Kei-ichi Ozaki et al. CANCER SCIENCE
- Isoform-Selective Histone Deacetylase Inhibitors
- (2008) Takayoshi Suzuki et al. CURRENT PHARMACEUTICAL DESIGN
- Anticancer properties of the novel nitric oxide-donating compound (S,R)-3-phenyl-4,5-dihydro-5-isoxazole acetic acid-nitric oxide in vitro and in vivo
- (2008) D. Maksimovic-Ivanic et al. MOLECULAR CANCER THERAPEUTICS
- Network pharmacology: the next paradigm in drug discovery
- (2008) Andrew L Hopkins Nature Chemical Biology
- Incorporation of histone deacetylase inhibition into the structure of a nuclear receptor agonist
- (2008) L. E. Tavera-Mendoza et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatment
- (2008) C. Colussi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylase inhibition accelerates the early events of stem cell differentiation: transcriptomic and epigenetic analysis
- (2008) Efthimia Karantzal et al. GENOME BIOLOGY
- Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells
- (2007) F Condorelli et al. BRITISH JOURNAL OF PHARMACOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started